Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,603 public trials 2,148 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, Not Recruiting

A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer

NCT03661320

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Local Institution - 0022 Tucson, Arizona, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Local Institution - 0021 Littleton, Colorado, United States
  • Local Institution - 0036 Pensacola, Florida, United States
View all 172 locations
View Trial Details
Active, Not Recruiting

Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

NCT06256432

Conditions
Acute Kidney Injury, Ascites Hepatic, Digestive System Diseases, +13 more
Locations
  • Aster CMI Hospital Bangalore, Karnataka, India
  • Sir HN Reliance Hospital Foundation Mumbai, Maharashtra, India
  • All India Institute of Medical Sciences New Delhi, National Capital Territory of Delhi, India
  • Asian Institute of Gastroenterology (AIG) Hyderabad, Telangana, India
View Trial Details
Active, Not Recruiting

Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer

NCT01038778

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions